• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,953.95(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,569.30(%)
  • Sai Life
    1,815.55 1,815.55(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

RPG Life Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Goenka R P
  • BSE Code : 29175.0
  • ISIN : INE105J01010
2,553.70 -42 (-1.62%)
  • As on 06 Nov 2026 (EOD)

  • Today’s Low

    2,520.10

  • Today’s High

    2,580.00

  • Open

    2,580.00

  • Perv Close

    2,595.70

  • 52W Low

    1,733.00

  • 52W High

    3,127.80

Key Indicators

  • P/E(TTM)

    37.93

  • Mar.Cap (₹Cr.)

    4,223.57

  • Div & Yield %

    0.94

  • Book Value(₹)

    374.41

  • Debt-Equity Ratio

    -1.62

  • AGM Date

    06-Nov-2026

  • EPS

    67.40

  • P/E Ratio

    37.93

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    4,223.57

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.23

  • BV (₹)

    374.40

  • Sales( ₹ in Cr.)

    707.52

  • NP (in Cr.)

    109.67

  • NP Var(%)

    -5.0

  • Div%

    300.0

  • CPS (₹)

    79.30

  • EPS (₹)

    66.30

  • Traded Value (₹ in Lakhs)

    4,273.35

  • 52 Week High

    3,127.80

  • 52 Week Low

    1,733.00

  • Price BSE

    2584.0

  • Price NSE

    2,596.00

  • Market Capital( in Cr.)

    4,273.35

  • P/C Ratio

    32.60

  • P/E Ratio

    39.00

  • Price Vs.BV

    66.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 707.52 653.43 582.05 512.81 440.16 389.14
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 707.52 653.43 582.05 512.81 440.16 389.14
Other Income 50.29 111.61 7.21 4.80 2.99 0.91
Stock Adjustments 21.99 -8.61 -2.70 7.30 25.21 5.01
Total Income 779.80 756.43 586.56 524.91 468.36 395.06
EXPENDITURE :            
Raw Materials 274.08 205.40 181.83 178.17 167.03 136.11
Power and Fuel Cost 18.50 17.66 14.36 13.65 12.69 11.27
Employee Cost 141.48 126.14 132.15 117.06 99.97 94.66
Other Manufacturing Expenses 29.35 28.23 26.07 21.60 22.61 18.48
Selling and Administration Expenses 99.85 95.49 80.47 73.63 71.19 58.40
Miscellaneous Expenses 39.09 27.61 15.33 12.47 4.63 4.30
Employee Benefit Expenses 141.48 126.14 132.15 117.06 99.97 94.66
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 602.35 500.53 450.21 416.58 378.12 323.22
Operating Profit 177.45 255.90 136.35 108.33 90.24 71.84
Interest 1.77 1.59 1.44 1.15 1.41 1.79
Gross Profit 175.68 254.31 134.91 107.18 88.83 70.05
Depreciation 21.48 21.43 17.07 15.50 15.66 16.47
Profit Before Tax 154.20 232.88 117.84 91.68 73.17 53.58
Current Tax 34.75 49.69 32.54 24.35 22.76 17.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.28 -0.05 -2.36 -0.31 -1.07 -3.57
Reported Net Profit 115.17 183.24 87.66 67.64 51.48 40.00
Extraordinary Items 5.50 67.66 0.77 -0.57 0.61 -0.01
Adjusted Net Profit 109.67 115.58 86.89 68.21 50.87 40.01
Adjustment below Net Profit -0.64 -1.10 -0.56 0.07 -0.25 -0.12
P & L Balance brought forward 474.16 318.48 251.23 199.40 160.08 120.20
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 39.69 26.46 19.85 15.88 11.91 0.00
P & L Balance carried down 549.00 474.16 318.48 251.23 199.40 160.08
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 300.00 300.00 200.00 150.00 120.00 90.00
Dividend Per Share(Rs) 24.00 24.00 16.00 12.00 9.60 7.20
Earnings Per Share-Unit Curr 69.64 110.80 53.01 40.90 31.13 24.19
Earnings Per Share(Adj)-Unit Curr 69.64 110.80 53.01 40.90 31.13 24.19
Book Value 366.06 320.80 226.67 186.00 154.66 130.88
Book Value(Adj)-Unit Curr 366.06 320.80 226.67 186.00 154.66 130.88

Shareholding Pattern

  • Promoter Group

    72.95%

  • Public Share Holding

    27.05%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,108,771 18.80 3,108,771 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 35,662 0.22 35,662 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 8,920,874 53.94 8,920,874 7
Others 0 0.00 0 0
Sub Total 12,065,307 72.95 12,065,307 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,842 0.01 1 6
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 144,487 0.87 144,487 39
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 150 0.00 150 1
Insurance Companies 34,660 0.21 34,660 1
Mutual Funds / UTI 6,754 0.04 6,754 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,598,608 9.67 1,598,608 10
Trusts 118 0.00 118 1
Venture Capital Funds 0 0.00 0 0
Sub total 1,786,619 10.80 1,784,778 61
2] Non Institution
Bodies Corporate 131,010 0.79 129,926 217
Clearing Members 4,131 0.03 4,131 14
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 96,790 0.59 96,518 727
Foreign Non Institution Other 2,850 0.02 0 2
Hindu Undivided Families 102,486 0.62 102,472 482
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 33,327 0.20 33,327 1
Individuals holding nominal share capital up to Rs. 1 lakh 2,134,297 12.90 1,999,726 22,786
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 83 0.00 83 1
Others 179,203 1.08 179,203 1
Sub Total 2,687,089 16.25 2,548,065 24,249
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,539,015 100.00 16,398,150 24,330

Company Background

RPG Life Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • RPG Life Sciences Ltd
  • BSE Code : 29175.0
  • ISIN : INE105J01010

  • Incorporation Year

    2007

  • Registered Office

    RPG House
    463 Dr Annie Besant Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-24981650

  • FAX

    91-022-24970127

  • Chairman

    H V Goenka

  • Managing Director

    ASHOK NAIR

  • Company Secretary

    Rajesh Shirambekar

  • Auditor

    S R B C & Co LLP

  • Face Value

    8

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

RPG Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
RPG LifeScience. 2,556.55 733.06 707.52 39.93 26.57
Abbott India 26,340.05 7,217.19 6,929.05 34.66 43.78
Astrazeneca Phar 6,387.90 2,304.07 2,275.58 94.15 27.86
Glaxosmi. Pharma 2,524.85 3,932.76 3,790.20 37.52 58.17
Evonile Pharma 1,762.40 393.10 354.33 -1,087.90 15.94
Cipla 1,409.00 20,102.60 18,979.95 42.94 13.88
Bliss GVS Pharma 603.40 773.53 729.81 39.34 12.51
Amrutanjan Healt 513.30 520.13 502.55 25.90 24.16
Fermenta Biotec. 447.05 474.15 450.25 20.87 18.77
Guj. Themis Bio. 379.05 168.25 165.82 101.35 18.05
Ambalal Sarabhai 35.25 19.52 3.94 65.28 6.77